New Therapeutic Strategies for Adult Patients With Persistent and Chronic Immune Thrombocytopenia

Choosing treatment for patients with persistent or chronic ITP is incredibly complex with many factors involved. Take this opportunity to deepen your understanding of current and evolving best practices for the treatment of patients with ITP that has not responded well to initial therapy. 

Share

Program Content

Activities

New ITP Strategies
New Therapeutic Strategies for Adult Patients With Persistent and Chronic Immune Thrombocytopenia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 15, 2019

Expires: January 14, 2020

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Dova Pharmaceuticals

Novartis Pharmaceuticals Corporation